Sanofi: Signed Letter Of Intent With Russia's Prominvest
PARIS -(Dow Jones)- French pharmaceutical company Sanofi-Aventis (SNY) said
Friday it has signed a Memorandum of Understanding with Prominvest, a fully
owned subsidiary of the Russian State Corporation Rostekhnologii, confirming its
intent to participate in the "Pharmpolis Project" using the new modern Sanofi-
Aventis insulin factory located in Russia as a pilot initiative.
MAIN FACTS:
- . The document was signed by Mikhail Shelkov, General Director of LLC
Prominvest and Christopher A. Viehbacher, Chief Executive Officer of Sanofi-
Aventis, during the Franco-Russian Intergovernmental Seminar held in the Castle
of Rambouillet, France, in the presence of Vladimir Putin, Prime Minister of the
Russian Federation, and François Fillon, Prime Minister of France.
- The "Pharmpolis Project" is part of the overall effort of the Russian
Government to localize innovative drug manufacturers in Russia, to attract high
technology platforms and to provide manufacturers with sufficient resources,
effective business environment and proper supplier network to foster the
expansion of the pharmaceutical market.
- By Paris Bureau, Dow Jones Newswires; +331-4017-1740; paris@
priority.emea.dowjones.com
(END) Dow Jones Newswires
11-27-090831ET
Copyright (c) 2009 Dow Jones & Company, Inc.
|